Search for: "TEVA PHARMACEUTICALS USA, INC."
Results 121 - 140
of 480
Sort by Relevance
|
Sort by Date
25 Jun 2018, 7:51 am
Teva Pharmaceuticals USA: Whether, under federal patent law, an inventor’s sale of an invention to someone who is required to keep the invention confidential constitutes “prior art” for purposes of determining whether the invention is patentable. [read post]
25 Jun 2018, 7:03 am
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
21 Jun 2018, 4:00 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
20 Jun 2018, 5:00 pm
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
18 Jun 2018, 9:15 am
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229 (Supreme Court 2018), the petitioner has asked the Supreme Court to offer its statement on whether Congress altered the “on sale bar” to now apply only to non-confidential sales or offers. [read post]
7 Jun 2018, 4:59 pm
Ltd.; Teva Pharmaceuticals International GMGH; and Teva Pharmaceuticals USA, Inc. [read post]
18 Apr 2018, 1:02 pm
In Teva Pharmaceutical USA, Inc. v. [read post]
11 Apr 2018, 7:17 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
30 Mar 2018, 7:13 am
Teva Pharmaceuticals USA, Inc., 1-14-cv-00878 (DED March 28, 2018, Order) (Stark, USDJ) [read post]
21 Mar 2018, 1:34 pm
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
7 Mar 2018, 11:52 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Feb 2018, 7:31 am
Teva Pharmaceuticals USA, Inc., February 5, 2018, Stengel, L.). [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
11 Dec 2017, 5:16 pm
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
25 Oct 2017, 6:55 am
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 2:17 pm
TEVA Pharmaceuticals USA, INC. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 7:36 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED October 16, 2017, Order) (Bryson, CJ) [read post]
